NORTH READING, MA--(Marketwired - Jan 20, 2016) - TraceLink Inc., the world's largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced NEXUS '16 -- the company's annual gathering of business leaders and pharmaceutical supply chain professionals dedicated to shaping the future of global drug traceability for Life Sciences. The two-day event will be held on October 19 and 20, at the Revere Hotel Boston, with a special evening event at the John F. Kennedy Presidential Library & Museum. Registration for NEXUS '16 is now open, with early purchase discounts available for all tickets sales before June 1, 2016.

"It's often difficult to find time away from the office to sit down with industry peers, learn from each other, share ideas, and come together as a community to create business value that results in protecting channel integrity and promoting patient health," said Jon Hahn, CIO of FFF Enterprises, and attendee of TraceLink NEXUS '15. "I would highly recommend that anyone involved with regulatory laws and supply chain compliance for their company attend and benefit from NEXUS this coming October."

Shabbir Dahod, president and CEO of TraceLink commented, "TraceLink NEXUS is an opportunity for pharmaceutical suppliers to come together and dig deep on specific issues that impact their ability to achieve compliance as a whole across the supply chain. As life sciences companies work to address a plethora of track and trace challenges over the next few years, most are working in isolation on their unique issues. However, for track and trace initiatives to be successful, companies must work more closely together. Our theme for NEXUS '16 emphasizes this critical need and attendees won't experience any other event during the year that draws this level of collaborative insights from such a wide range of supply chain partners."

TraceLink NEXUS '16: Mastering Global Traceability with a Digital Supply Chain Network

As regulatory deadlines near in a range of countries across the world, pharmaceutical suppliers attending NEXUS '16 will benefit from industry thought leaders, supply chain visionaries, and track and trace pioneers and the perspectives they share on successful track and trace implementations and long-term value for life sciences businesses. Attendees will be able to participate in keynotes, educational tracks and interactive workshops that explore:

  • Drug traceability from all segments of the supply chain, including pharma manufacturers, CMOs, distributors, pharmacy chains, health systems, and independent drugstores;
  • Implementation plans for achieving comprehensive compliance coverage in multiple countries;
  • Real-world case studies from businesses that have deployed successful track and trace programs; and,
  • Exciting opportunities for near-term and long-term value that will result from leveraging digital supply chain networks.

At the conclusion of the first day of the conference, all attendees are invited to a special evening event at the John F. Kennedy Presidential Library & Museum, where they will have exclusive access to historical materials related to the life, leadership, and legacy of the thirty-fifth president of the Unites States.

Registration and Attendance Fees for NEXUS '16

NEXUS '16 is open to everyone in the life sciences community, and registration fees vary based on customer status and early bird discounts:

  • $595 USD for all participants who register prior to June 1, 2016;
  • $595 USD for all TraceLink customers, regardless of registration date; and,
  • $795 USD for any participant who registers for the conference after June 1, 2016, and who is not a TraceLink customer at the time of registration.

In addition, anyone who attended NEXUS in 2015 and registers by March 1, 2016 will be entered into a drawing to win one of three fully paid guest suite accommodations at the Revere Hotel Boston on Tuesday, October 18 and Wednesday, October 19. The winners will be chosen at random after March 1.

To learn more about TraceLink NEXUS '16, hear attendees talking about the value of former NEXUS events, and to take advantage of limited time ticket sales discounts, please visit

About TraceLink
TraceLink is the world's largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses, including 16 of the top-20 global pharmaceutical companies, trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by FirstMark Capital, Volition Capital and Fidelity Biosciences.

Contact Information:


Laura MacSweeney
(for TraceLink)
Red Javelin Communications
(781) 395-6420